Truly opposite is defined by identity of units with complementary anatomy or structure to form a pair,*** and *** or corresponding structure or form permits reciprocal function of these units or“opposites”.Focus on...
详细信息
Truly opposite is defined by identity of units with complementary anatomy or structure to form a pair,*** and *** or corresponding structure or form permits reciprocal function of these units or“opposites”.Focus on“Identity”or“function”determines one’s view as to whether these units are“opposites”or“complementary”.“Identity”is unique&exclusive,whereas,function requires inclusivity,specificity&reciprocal interaction,contributed to by both units to form a dynamic partnership or *** interaction matters as it permits an inclusive ***&awareness of surroundings that impact on relationships and/or personal interaction is represented here by a surrounding circle or sense of purpose and represents the extension of immediate context involving both units in a paired relationship of structural complementary units within their encompassing surroundings or contextual *** reference is the ethical key to understanding situations&circumstance so serves as the key to ethics,morality&*** Relationship Equation,E=1=m.c-1,provides a simple model of understanding usually viewed as complex *** offers an approach to solving identity issues by viewing these as complementary and functional rather than as *** place of identity as the focus it introduces context and reciprocal interaction of complementary units of a *** as part of a whole transfers the focus from self to other or both and to an awareness of higher purpose in the Oneness of function of Creation as(m.c-1)=E=*** influence is taken into account by viewing the Eco-social environment or Eco-society as *** of environment on one or other unit in a pair or on both&vice versa affects ***&adaptation to environmental change leads to evolution when the pair thrives better in this new Eco-social *** part of a functional whole,as a functional unit or as a functioning pair,adds purp
AIM: To evaluate daclatasvir vs telaprevir, each combined with peginterferon alfa-2a/ribavirin(peg IFN/RBV), in treatment-naive hepatitis C virus(HCV) genotype(GT) 1-infected ***: In this phase 3, randomized, open-lab...
详细信息
AIM: To evaluate daclatasvir vs telaprevir, each combined with peginterferon alfa-2a/ribavirin(peg IFN/RBV), in treatment-naive hepatitis C virus(HCV) genotype(GT) 1-infected ***: In this phase 3, randomized, open-label, noninferiority study, 602 patients were randomly assigned(2:1) to daclatasvir vs telaprevir, stratified by IL28 B rs12979860 host genotype(CC vs non-CC), cirrhosis status(compensated cirrhosis vs no cirrhosis), and HCV GT1 subtype(GT1a vs GT1b). Patients were selected by study inclusion criteria from a total of 793 enrolled patients. Patients received daclatasvir 60 mg once daily or telaprevir 750 mg 3 times daily plus peg IFN/RBV. Daclatasvir recipients received 24 wk of daclatasvir plus peg IFN/RBV; those without an extended rapid virologic response(e RVR; undetectable HCV-RNA at weeks 4 and 12) received an additional 24 wk of peg IFN/RBV. Telaprevir-treated patients received 12 wk of telaprevir plus peg IFN/RBV followed by 12(with e RVR) or 36(no e RVR) wk of peg IFN/RBV. The primary objective was to compare for noninferiority of sustained virologic response rates at posttreatment week 12(SVR12) in GT1b-infected patients. Key secondary objectives were to demonstrate that the rates of anemia(hemoglobin < 10 g/d L) and rashrelated events, through week 12, were lower with daclatasvir + peg IFN/RBV than with telaprevir + peg IFN/RBV among GT1b-infected patients. Resistance testing was performed using population-based sequencing of the NS5 A region for all patients at baseline, and for patients with virologic failure or relapse and HCV-RNA ≥ 1000 IU/m L, to investigate any link between NS5 A polymorphisms associated with daclatasvir resistance and virologic outcome. RESULTS: Patient demographics and disease characteristics were generally balanced across treatment arms; however, there was a higher proportion of black/African Americans in the daclatasvir groups(6.0% and 8.2% in the GT1 b and GT1 a groups, respectively) than in the telaprevi
暂无评论